Ocreotide Acetate-Injection
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Pharmaceuticals
Product name | Ocreotide Acetate-Injection | Certification | - |
---|---|---|---|
Category | Pharmaceuticals | Ingredients | - |
Keyword | injection , octreotide , somatostatin , ocreotide acetate-injection | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | - |
Supply type | - | HS code | - |
Product Information
Octstatin-Inj. is a long acting Somatostatin.
Structural Characteristics is below;
- Synthetic cyclic octa-peptide, which contains active 4 AA sequence (Phe-Trp-Lys-Thr)
- Substitute AAs to D-stereoisomer to prevent Proteolytic degradation
- It reinforces inhibition of GH secretion in hypothalamus, and reduces inhibition of insulin secretion in pancreas.
Application fields;
- Prevention of Complications after Pancreatic Surgery
- Decrease growth hormone and/or IGF-1(somatomedin C) level
- Symptoms of GEP NE tumors
- Gastro-esophageal Varicelal Bleeding
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- LEE, KWANG IN
- Address
- 7, Yangjipyeon 2-ro, Uiwang-si, Gyeonggi-do, Korea
- Product Category
- Pharmaceuticals,Wound Dressing Equipments
- Year Established
- 2005
- No. of Total Employees
- 51-100
- Company introduction
-
BMI Korea Co., Ltd. has been growing into a company that receives new attention in the industry for a short period of time since its establishment in 2005, but through creative and autonomous R&D to create future values, a passion for constantly challenging and changing, and a young and healthy corporate culture.
We are making every effort to research and develop differentiated biopharmaceuticals and medical devices, and based on this, we will do our best to realize our goal and dream of becoming a global leader in the health care sector.
thank you.
- Main Product